| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1278535B1 Uses of tgap7 for the modulation of leucocyte activation |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |
| 06/25/2008 | EP1015027B1 Process for preparing conjugate vaccines including free protein |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208336A Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents |
| 06/25/2008 | CN101208075A Liposome composition for induction of immunity |
| 06/25/2008 | CN101205553A Method for preparing recombinant glossy ganoderma immunomodulatory protein |
| 06/25/2008 | CN101205542A Construction method of shRNA expression carrier for inhibiting core1 beta1-3 galactosyltransferase and use thereof |
| 06/25/2008 | CN101205234A Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
| 06/25/2008 | CN101204580A Application of Vibrio alginolyticus-OmpA as animal immunity regulator |
| 06/25/2008 | CN101204578A Extrasin combinationpreparation for immunomodulation, preventing tissue damage and reparative regeneration |
| 06/25/2008 | CN101204546A Chinese traditional medicine preparation for allergic rhinitis |
| 06/25/2008 | CN101204467A External medicine for acute eczema |
| 06/25/2008 | CN101204409A Process for preparing ginseng |
| 06/25/2008 | CN101204202A Ruminant humus pellet feed |
| 06/25/2008 | CN101204196A Feed soybean oligosaccharide powder and manufacture method thereof |
| 06/25/2008 | CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph |
| 06/25/2008 | CN100396771C New microbe gene stock similar to lactobacillus casei GM-O80, and application for treating disease related to irritability |
| 06/25/2008 | CN100396769C Novel probiotics for pet food applications |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396676C Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/25/2008 | CN100396277C Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390906 Forming ketone intermediates to terfenadine carboxylic acid metabolite; by use of pure regioisomer of 4-(Cyclopropyl-oxo-methyl)-alpha,alpha-dimethylphenylacetic acid |
| 06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
| 06/24/2008 | US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 06/24/2008 | US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 06/24/2008 | US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
| 06/24/2008 | US7390797 Fused indazole compounds |
| 06/24/2008 | US7390658 Lymphoid dendritic cells generated from hematopoietic stem cells which encode viricidal and antitumor agents for preventing tumor metastasis and viral infection; immunotherapy |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/24/2008 | US7390483 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/24/2008 | US7390411 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/19/2008 | WO2008073770A1 Use of pkc inhibitors in transplantation |
| 06/19/2008 | WO2008073466A2 Alpha b-crystallin as a therapy for inflammation |
| 06/19/2008 | WO2008073463A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | WO2008072784A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 06/19/2008 | WO2008072725A1 Composition containing agaricus blazei murill |
| 06/19/2008 | WO2008072724A1 Pyrazole derivative |
| 06/19/2008 | WO2008072682A1 Imidazo[1,2-b]pyridazine derivative |
| 06/19/2008 | WO2008071974A2 Use of pi3k m-tor and akt inhibitors to induce f0xp3 expression and generate regulatory t cells |
| 06/19/2008 | WO2008071701A1 Expression of transgenic t cell receptors in lak-t cells |
| 06/19/2008 | WO2008071605A2 Methods of treating inflammatory diseases |
| 06/19/2008 | WO2008070982A1 Archaeal polar lipid aggregates for administration to animals |
| 06/19/2008 | WO2008070927A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 06/19/2008 | WO2008051862A3 Immunopotentiating compositions comprising beta-1,3/1,6-d-glucan and uses thereof |
| 06/19/2008 | WO2008049123A3 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 06/19/2008 | WO2008043570A8 Interferon type i supporting compounds |
| 06/19/2008 | WO2008035207A3 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 06/19/2008 | WO2008027584A3 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase |
| 06/19/2008 | WO2008009894A3 Use of imino sugars in immunotherapy |
| 06/19/2008 | WO2008008482A3 Altered br3-binding polypeptides |
| 06/19/2008 | WO2007058832A3 Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors |
| 06/19/2008 | US20080147131 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 06/19/2008 | US20080146810 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/19/2008 | US20080146632 Fc Receptor Modulating Compounds and Compositions |
| 06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/19/2008 | US20080146617 Methods of treating inflammatory diseases |
| 06/19/2008 | US20080146616 Indoles Useful in the Treatment of Inflammation |
| 06/19/2008 | US20080146614 Therapeutic Agents |
| 06/19/2008 | US20080146604 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders |
| 06/19/2008 | US20080146589 Chromenone derivatives |
| 06/19/2008 | US20080146578 Indolylmaleimide derivatives |
| 06/19/2008 | US20080146569 Nicotinamide Derivatives |
| 06/19/2008 | US20080146563 1,7-Naphthyridines as Pde4 Inhibitors |
| 06/19/2008 | US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145453 4-(piperimidine-2thione)phenyl derivatives; kinesin Eg5 inhibitor; anticarcinogenic agent; the aldehyde, the ketone and the thiourea are reacted together in the solid phase, grafted onto resin by esterification, and detached by hydrolysis |
| 06/19/2008 | US20080145441 Core of metal atoms of gold, silver or copper covalently linked to a carbohydrate group and to at least 20 ligands |
| 06/19/2008 | US20080145413 Lipids and lipid assemblies comprising transfection enhancer elements |
| 06/19/2008 | US20080145399 coronary stent has a multilayer coatings for controlled release of immunosuppressive agent active materials, including a porous cover layer |
| 06/19/2008 | US20080145398 Coated implantable medical device |
| 06/19/2008 | US20080145396 Coated implantable medical device |
| 06/19/2008 | US20080145394 Coated implantable medical device |
| 06/19/2008 | US20080145342 Co-transplantation of hepatic stellate cells and graft |
| 06/19/2008 | US20080145333 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 06/19/2008 | CA2672601A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 06/19/2008 | CA2672585A1 Composition containing agaricus blazei murill |
| 06/19/2008 | CA2672468A1 Human antibodies that bind cd70 and uses thereof |
| 06/19/2008 | CA2672338A1 Archaeal polar lipid aggregates for administration to animals |
| 06/19/2008 | CA2672215A1 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | CA2671736A1 Use of endos for the treatment or prevention of igg-mediated diseases and conditions |
| 06/19/2008 | CA2671732A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 06/19/2008 | CA2671040A1 Use of pkc inhibitors in transplantation |
| 06/19/2008 | CA2660038A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |